Clinical Trial Update: EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial EMPIRE CF evaluated CTX-4430 in adults with cystic fibrosis; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• CTX-4430

Snippet

Sponsor: Celtaxsys, Inc. | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2019-07-25